End of the New Zealand asthma mortality epidemic

作者: N Pearce , R Beasley , J Crane , C Burgess , R Jackson

DOI: 10.1016/S0140-6736(95)91159-6

关键词:

摘要: Abstract Summary In 1989, a case-control study reported that inhaled fenoterol was associated with the epidemic of asthma deaths had affected New Zealand since 1976. The Department Health issued warnings about safety and restricted its availability. time trends are consistent hypothesis main factor in mortality epidemic. commenced when introduced 1976, death rate remained highest world for more than decade. After publication study, fell by half has now low further 3 years (1990-92). Time-trend data do not suggest class effect beta-agonists epidemic: there no association between beta-agonist sales start epidemic, total actually increased slightly during 1989-90 came to an end. also inconsistent may have occurred because underprescribing corticosteroids. Similarly, time-trend is hypotheses postulating major role social factors such as unemployment. Data on should be assessed caution, can many factors. Nevertheless, being cause significant other suggested causes.

参考文章(26)
S. Suissa, P. Ernst, W. O. Spitzer, Asthma deaths in New Zealand. BMJ. ,vol. 305, pp. 889- 890 ,(1992) , 10.1136/BMJ.305.6858.889
J.D. Wilson, D.C. Sutherland, A.C. Thomas, Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? The Lancet. ,vol. 317, pp. 1235- 1237 ,(1981) , 10.1016/S0140-6736(81)92403-X
N Pearce, J Grainger, M Atkinson, J Crane, C Burgess, C Culling, H Windom, R Beasley, Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax. ,vol. 45, pp. 170- 175 ,(1990) , 10.1136/THX.45.3.170
M.R. Sears, D.R. Taylor, C.G. Print, D.C. Lake, Q. Li, E.M. Flannery, D.M. Yates, M.K. Lucas, G.P. Herbison, Regular inhaled beta-agonist treatment in bronchial asthma The Lancet. ,vol. 336, pp. 1391- 1396 ,(1990) , 10.1016/0140-6736(90)93098-A
Ralph L Horwitz, Walter Spitzer, Sonia Buist, Donald Cockcroft, Pierre Ernst, Brian Habbick, Brenda Hemmelgarn, Mary McNutt, Anthony S. Rebuck, Samy Suissa, Clinical Complexity and Epidemiologic Uncertainty in Case-Control Research: Fenoterol and Asthma Management Chest. ,vol. 100, pp. 1586- 1591 ,(1991) , 10.1378/CHEST.100.6.1586
J. Crane, C. Burgess, N. Pearce, R. Beasley, R. Jackson, Asthma deaths in New Zealand. BMJ. ,vol. 304, pp. 1307- 1307 ,(1992) , 10.1136/BMJ.304.6837.1307
R. Beasley, H. Windom, N. Pearce, C. Burgess, J. Crane, Asthma mortality and inhaled beta agonist therapy Australian and New Zealand Journal of Medicine. ,vol. 21, pp. 753- 763 ,(1991) , 10.1111/J.1445-5994.1991.TB01385.X
Neil Pearce, Julian Crane, Carl Burgess, Richard Beasley, β-Agonist Use and Death from Asthma JAMA. ,vol. 271, pp. 822- 823 ,(1994) , 10.1001/JAMA.1994.03510350029021
S Suissa, P Ernst, J F Boivin, R I Horwitz, B Habbick, D Cockroft, L Blais, M McNutt, A S Buist, W O Spitzer, A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. American Journal of Respiratory and Critical Care Medicine. ,vol. 149, pp. 604- 610 ,(1994) , 10.1164/AJRCCM.149.3.8118625